Skip to main content
. Author manuscript; available in PMC: 2015 Aug 12.
Published in final edited form as: J Med Chem. 2013 Apr 26;56(9):3733–3741. doi: 10.1021/jm400288z

Table 1.

Properties of Ritonavir and Compounds 1–3

442 nm band (Fe2+) Ksa (nM) Eo,7b (mV) kfastc (s−1) Tmd (°C) IC50e (nM)
ritonavir +f 51 ± 10f −350 ± 5f 1.4 ± 0.3f 54.8 ± 0.1 550 ± 50
1 22 ± 4 <<-370 1.9 ± 0.3 56.5 ± 0.2 280 ± 40
2 ± 570 ± 30 ≈ −370 2.2 ± 0.4 54.8 ± 0.1 3400 ± 60
3 + 25 ± 5 −350 ± 5 7.0 ± 0.5 57.2 ± 0.2 130 ± 15
a

Spectral dissociation constant.

b

Midpoint redox potential of the inhibitor-bound CYP3A4. Eo,7 of the ligand-free CYP3A4 is ~−300 mV.7

c

Rate constant of the fast phase of the ligand binding reaction.

d

Melting temperature of the CYP3A4-inhibitor complex. Tm for the ligand-free CYP3A4 in the absence and presence of 2% DMSO is 52.6 ± 0.1 and 52.1 ± 0.1 °C, respectively.

e

Concentration required for half-maximal inactivation of recombinant CYP3A4.

f

Determined previously.7